The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 403.00
Bid: 398.50
Ask: 411.00
Change: -2.50 (-0.62%)
Spread: 12.50 (3.137%)
Open: 404.00
High: 406.00
Low: 401.00
Prev. Close: 405.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Community Passport

5 Jul 2017 11:44

RNS Number : 2033K
Banco Santander S.A.
05 July 2017
 

 

 

 

 

MATERIAL FACT ANNOUNCEMENT

 

 

Further to the relevant fact communication dated 4 July 2017 in connection with the capital increase with pre-emptive subscription rights of Banco Santander, S.A. (the "Capital Increase" and "Banco Santander", respectively) (registry number 254,243), Banco Santander informs that the Spanish Securities Market Commission ("CNMV"), pursuant to Article 39 of the reinstated text of the Securities Market Law, as approved by means of Royal Legislative Decree 4/2015, of 23 October, has granted the "Community Passport" to the Informative Prospectus in connection with the Capital Increase (which is comprised of the Share Registration Document, the Share Securities Note and the Summary), which it has notified to the competent authorities in Italy, Poland, Portugal and the United Kingdom in order for the Informative Prospectus to gain cross-border effectiveness and be used in connection with the Capital Increase in such jurisdictions.

 

The Informative Prospectus is available at the web pages of the CNMV (www.cnmv.es) and of Banco Santander (www.santander.com).

 

 

Boadilla del Monte (Madrid), 5 July 2017

 

IMPORTANT INFORMATION

The present announcement is not an informative prospectus but an informative communication and investors should not subscribe any new shares of Banco Santander, S.A. ("Banco Santander" or the "Bank") or purchase any pre-emptive subscription rights for new shares of the Bank's Capital Increase referred to herein except on the basis of the information contained in the prospectus in connection with the capital increase which has been registered with the Comisión Nacional del Mercado de Valores ("CNMV") on 4 July 2017 and is publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es). Likewise, the Bank has obtained the community passport of the informative prospectus for the purposes of it being cross-border effective in the United Kingdom, Italy, Portugal and Poland.

This communication does not constitute an offer to sell, or a solicitation of offers to subscribe, the pre-emptive subscription rights or the new shares of the share capital increase in any jurisdiction in which such offer or solicitation is unlawful or, as the case may be, until the applicable requirements for those purposes have been met. The distribution of this communication and/or the prospectus and/or the transfer of pre-emptive subscription rights and/or new shares into jurisdictions other than Spain, the United Kingdom, Italy, Portugal and Poland may be restricted by law. Persons who gain access to the information set out herein should be aware of and comply with any such restrictions. Any failure to comply with them may constitute a breach of the securities laws of any such jurisdiction.

This communication (i) must not be construed in any way to be a request to buy or to sell securities or any related financial instruments in Brazil, and (ii) must not be construed in any way to be a public offering of securities in Brazil. The Brazilian Securities Commission (Comissão de Valores Mobiliários) has not authorised the public offering of shares to which this communication refers nor of any securities related to such shares. Hence, the said shares cannot be offered to the public in Brazil.

The Bank has filed a registration statement (including a prospectus) with the SEC for the capital increase and the offering of new shares and subscription rights to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Bank has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, you may obtain a copy of the prospectus from Citigroup by calling toll free 1-800-831-9146 or UBS by calling toll free 1-877-387-2275.

The public offering of the new Banco Santander shares has been authorised by the Argentine National Securities Commission, and the Subscription Announcement (Aviso de Suscripción) setting forth the procedure and term for the subscription for new shares in Argentina has already been published in such jurisdiction. The capital increase to which this announcement refers and the Argentine offering will have the same terms and conditions, save as otherwise provided in the relevant Subscription Announcement. The Bank envisages to request the admission to trading of the new shares in the Buenos Aires stock exchange.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUWCMUPMGUA
Date   Source Headline
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.